Figure 7From: Focused ultrasound-induced blood–brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study Tumor progression followed by MRI. Representative T2 MR imaging to follow brain tumor progression (7 days observation time interval; 3 time points in total) among the experimental groups.Back to article page